To receive daily emails from Breaking Christian News to your inbox CLICK HERE

"Now that we know that we can target the basic molecular defects in Alzheimer's disease, we can hope for treatments far better—and more specific—than anything we have today." -Dr. Gerald Weissmann

A new ray of hope has broken through the clouded outcomes associated with Alzheimer's disease. A new research report published in January 2013 print issue of the FASEB Journal (Federation of the American Societies for Experimental Biology) by scientists from the National Institutes of Health shows that when a molecule called TFP5 is injected into mice with disease that is the equivalent of human Alzheimer's, symptoms are reversed and memory is restored—without obvious toxic side effects.

"We hope that clinical trial studies in AD patients should yield an extended and a better quality of life as observed in mice upon TFP5 treatment," said Harish C. Pant, Ph.D., a senior researcher involved in the work from the Laboratory of Neurochemistry at the National Institute of Neurological Disorders at Stroke at the National Institutes of Health in Bethesda, MD. "Therefore, we suggest that TFP5 should be an effective therapeutic compound." (Photo by: Cécile Graat)

To make this discovery, Pant and colleagues used mice with a disease considered the equivalent of Alzheimer's. One set of these mice were injected with the small molecule TFP5, while the other was injected with saline as placebo. The mice, after a series of intraperitoneal injections of TFP5, displayed a substantial reduction in the various disease symptoms along with restoration of memory loss. In addition, the mice receiving TFP5 injections experienced no weight loss, neurological stress (anxiety) or signs of toxicity. The disease in the placebo mice, however, progressed normally as expected. TFP5 was derived from the regulator of a key brain enzyme, called Cdk5. The over activation of Cdk5 is implicated in the formation of plaques and tangles, the major hallmark of Alzheimer's disease.

"The next step is to find out if this molecule can have the same effects in people, and if not, to find out which molecule will," said Gerald Weissmann, M.D., Editor-in-Chief of the FASEB Journal. "Now that we know that we can target the basic molecular defects in Alzheimer's disease, we can hope for treatments far better—and more specific—than anything we have today."

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

Hollywood Revival? Candace Cameron Bure on Jesus Invading Hollywood: 'It's Pretty Incredible'

'Absolute Miracle': Texas Boy Survives After Being 'Sucked Up' by Deadly Tornado

UK Bans Gender-Neutral Bathrooms for New Buildings and Rebuilds

IDF Captures Strategic Rafah Border Crossing Between Egypt and the Southern Gaza Strip

REVEALED: Attorney Prosecuting Trump in Manhattan Took THOUSANDS in DNC Cash.

Former CNN anchor Chris Cuomo reveals he is suffering from COVID vaccine side effects

'Unsung Hero', Go See This Movie If You Get a Chance; a Beautiful Story of a Wonderful and Famous Christian Music Family

Nolte: Exclusive—71 Percent Want Disney to End LGBTQ Agenda, Brand in Freefall

Chick-fil-A Set to Convert Strip Club, Site of Recent Murder into a New Restaurant

Wow! Man Points Gun at Pastor Delivering Sermon, What Happened Next Is a 'Miracle'

US Service Members Waiting for Congress and Department of Defense to Acknowledge COVID Shot Mandate Was Unlawful and Harmful

No Deal with Hamas as Israel Marks Holocaust Remembrance Day

Trump Hit With 10th Gag Order Violation, Judge Weighs Jail Time

Florida Governor Ron DeSantis Bans Woke Indoctrination in Teacher Training Programs

Arizona Dem Governor Katie Hobbs Repeals State's Near-Total Abortion Ban

'Darkness Doesn't Stand a Chance': A Great Multitude Takes Part in 2024 National Day of Prayer

City of Muenster in Texas Becomes 69th 'Safe Haven' City for the Unborn in the US

Clues: US Anti-Israel Protests Fueled by Major Foreign Funding; Backed by Iran, Hamas

Top Biden DOJ Official Busted for Lying About Past Arrest

Victory for Election Integrity: Court Blocks Undated Ballots

Steve Shultz, Managing Editor
Founder and Owner

Aimee Herd, Editor